UB Paderborn / Katalog / Suche / in CDI

1 – 25 von 1.251

Sortiert nach

Neoadjuvant chemotherapy followed by concurrent chemoradiotherapy versus concurrent chemoradiotherapy alone in locoregionally advanced nasopharyngeal carcinoma: A phase III multicentre randomised controlled trial

European journal of cancer (1990), 2017-04, Vol.75, p.14-23

2017

Link zum Volltext

Verfügbarkeit prüfen

Circular RNAs function as ceRNAs to regulate and control human cancer progression

Molecular cancer, 2018-04, Vol.17 (1), p.79-11, Article 79

2018

Link zum Volltext

Verfügbarkeit prüfen

Neoantigen vaccine: an emerging tumor immunotherapy

Molecular cancer, 2019-08, Vol.18 (1), p.128-14, Article 128

2019

Link zum Volltext

Verfügbarkeit prüfen

Pyroptosis: a new paradigm of cell death for fighting against cancer

Journal of experimental & clinical cancer research, 2021-05, Vol.40 (1), p.153-153, Article 153

2021

Link zum Volltext

Verfügbarkeit prüfen

Natural killer group 2D receptor and its ligands in cancer immune escape

Molecular cancer, 2019-02, Vol.18 (1), p.29-29, Article 29

2019

Link zum Volltext

Verfügbarkeit prüfen

PVT1 Promotes Cancer Progression via MicroRNAs

Frontiers in oncology, 2019-07, Vol.9, p.609-609

2019

Link zum Volltext

Verfügbarkeit prüfen

LncRNAs regulate the cytoskeleton and related Rho/ROCK signaling in cancer metastasis

Molecular cancer, 2018-04, Vol.17 (1), p.77-77, Article 77

2018

Link zum Volltext

Verfügbarkeit prüfen

Circular RNA circRNF13 inhibits proliferation and metastasis of nasopharyngeal carcinoma via SUMO2

Molecular cancer, 2021-08, Vol.20 (1), p.112-21, Article 112

2021

Link zum Volltext

Verfügbarkeit prüfen

Current Status of Immune Checkpoint Inhibitor Immunotherapy for Lung Cancer

Frontiers in oncology, 2021-08, Vol.11, p.704336-704336

2021

Link zum Volltext

Verfügbarkeit prüfen

LNCAROD is stabilized by m6A methylation and promotes cancer progression via forming a ternary complex with HSPA1A and YBX1 in head and neck squamous cell carcinoma

Molecular oncology, 2020-06, Vol.14 (6), p.1282-1296

2020

Link zum Volltext

Verfügbarkeit prüfen

Effects of tumor metabolic microenvironment on regulatory T cells

Molecular cancer, 2018-11, Vol.17 (1), p.168-168, Article 168

2018

Link zum Volltext

Verfügbarkeit prüfen

Chronic Stress Promotes Cancer Development

Frontiers in oncology, 2020-08, Vol.10, p.1492-1492

2020

Link zum Volltext

Verfügbarkeit prüfen

Emerging role of lipid metabolism alterations in Cancer stem cells

Journal of experimental & clinical cancer research, 2018-06, Vol.37 (1), p.118-118, Article 118

2018

Link zum Volltext

Verfügbarkeit prüfen

circ_100984‐miR‐432‐3p axis regulated c‐Jun/YBX‐1/β‐catenin feedback loop promotes bladder cancer progression

Cancer science, 2021-04, Vol.112 (4), p.1429-1442

2021

Link zum Volltext

Verfügbarkeit prüfen

EGFR-PKM2 signaling promotes the metastatic potential of nasopharyngeal carcinoma through induction of FOSL1 and ANTXR2

Carcinogenesis (New York), 2020-07, Vol.41 (6), p.723-733

2020

Link zum Volltext

Verfügbarkeit prüfen

Dynamic changes of phenotype and function of natural killer cells in peripheral blood before and after thermal ablation of hepatitis B associated hepatocellular carcinoma and their correlation with tumor recurrence

BMC cancer, 2023-05, Vol.23 (1), p.486-486

2023

Link zum Volltext

Verfügbarkeit prüfen

Transfer RNA-derived small RNAs in tumor microenvironment

Molecular cancer, 2023-02, Vol.22 (1), p.32-32, Article 32

2023

Link zum Volltext

Verfügbarkeit prüfen

A novel FBW7/NFAT1 axis regulates cancer immunity in sunitinib-resistant renal cancer by inducing PD-L1 expression

Journal of experimental & clinical cancer research, 2022-01, Vol.41 (1), p.38-38, Article 38

2022

Link zum Volltext

Verfügbarkeit prüfen

YTHDC1 is downregulated by the YY1/HDAC2 complex and controls the sensitivity of ccRCC to sunitinib by targeting the ANXA1-MAPK pathway

Journal of experimental & clinical cancer research, 2022-08, Vol.41 (1), p.1-250, Article 250

2022

Link zum Volltext

Verfügbarkeit prüfen

Influence of Technologic Advances on Outcomes in Patients With Unresectable, Locally Advanced Non–Small-Cell Lung Cancer Receiving Concomitant Chemoradiotherapy

International journal of radiation oncology, biology, physics, 2010-03, Vol.76 (3), p.775-781

2010

Link zum Volltext

Verfügbarkeit prüfen

FAIM2 Promotes Non-Small Cell Lung Cancer Cell Growth and Bone Metastasis by Activating the Wnt/β-Catenin Pathway

Frontiers in oncology, 2021-09, Vol.11, p.690142-690142

2021

Link zum Volltext

Verfügbarkeit prüfen

1 – 25 von 1.251

Suche als RSS-Feed

Aktive Filter

SpracheJapanisch

ThemaOncology

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(967)
Mit Volltextzugriff
(1.187)

Publikationsform

Artikel
(1.251)

Sprache

Erscheinungsjahr

n.n

Thema

Science & Technology
(1.230)
Life Sciences & Biomedicine
(1.219)
Humans
(621)
Female
(365)
Male
(324)
Middle Aged
(267)
Prognosis
(231)
Adult
(194)
Tumors
(194)
Aged
(192)
Animals
(192)
Cell Line, Tumor
(173)
Apoptosis
(169)
Metastasis
(169)
Cancer
(165)
Gene Expression
(162)
Cell Biology
(153)
Proteins
(153)
Chemotherapy
(145)

14 weitere anzeigen...

Weniger anzeigen...

Zeitschrift / Serie

5 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 30 Tagen
(1)
... seit 90 Tagen
(12)

Menü

Weitere Dienste

Einstellungen

Neoadjuvant chemotherapy followed by concurrent chemoradiotherapy versus concurrent chemoradiotherapy alone in locoregionally advanced nasopharyngeal carcinoma: A phase III multicentre randomised controlled trial

Circular RNAs function as ceRNAs to regulate and control human cancer progression

Neoantigen vaccine: an emerging tumor immunotherapy

Pyroptosis: a new paradigm of cell death for fighting against cancer

Natural killer group 2D receptor and its ligands in cancer immune escape

Induction chemotherapy with lobaplatin and fluorouracil versus cisplatin and fluorouracil followed by chemoradiotherapy in patients with stage III–IVB nasopharyngeal carcinoma: an open-label, non-inferiority, randomised, controlled, phase 3 trial

Induction chemotherapy followed by concurrent chemoradiotherapy versus concurrent chemoradiotherapy alone in locoregionally advanced nasopharyngeal carcinoma: long-term results of a phase III multicentre randomised controlled trial

PVT1 Promotes Cancer Progression via MicroRNAs

LncRNAs regulate the cytoskeleton and related Rho/ROCK signaling in cancer metastasis

Concurrent chemoradiotherapy plus adjuvant chemotherapy versus concurrent chemoradiotherapy alone in patients with locoregionally advanced nasopharyngeal carcinoma: a phase 3 multicentre randomised controlled trial

Circular RNA circRNF13 inhibits proliferation and metastasis of nasopharyngeal carcinoma via SUMO2

Current Status of Immune Checkpoint Inhibitor Immunotherapy for Lung Cancer

Concurrent chemoradiotherapy with nedaplatin versus cisplatin in stage II–IVB nasopharyngeal carcinoma: an open-label, non-inferiority, randomised phase 3 trial

LNCAROD is stabilized by m6A methylation and promotes cancer progression via forming a ternary complex with HSPA1A and YBX1 in head and neck squamous cell carcinoma

Effects of tumor metabolic microenvironment on regulatory T cells

Chronic Stress Promotes Cancer Development

Emerging role of lipid metabolism alterations in Cancer stem cells

circ_100984‐miR‐432‐3p axis regulated c‐Jun/YBX‐1/β‐catenin feedback loop promotes bladder cancer progression

EGFR-PKM2 signaling promotes the metastatic potential of nasopharyngeal carcinoma through induction of FOSL1 and ANTXR2

Dynamic changes of phenotype and function of natural killer cells in peripheral blood before and after thermal ablation of hepatitis B associated hepatocellular carcinoma and their correlation with tumor recurrence

Transfer RNA-derived small RNAs in tumor microenvironment

A novel FBW7/NFAT1 axis regulates cancer immunity in sunitinib-resistant renal cancer by inducing PD-L1 expression

YTHDC1 is downregulated by the YY1/HDAC2 complex and controls the sensitivity of ccRCC to sunitinib by targeting the ANXA1-MAPK pathway

Influence of Technologic Advances on Outcomes in Patients With Unresectable, Locally Advanced Non–Small-Cell Lung Cancer Receiving Concomitant Chemoradiotherapy

FAIM2 Promotes Non-Small Cell Lung Cancer Cell Growth and Bone Metastasis by Activating the Wnt/β-Catenin Pathway

Aktive Filter

Suchergebnisse filtern